Scarica l'app Stockscreener
31.79
1.63%
0.51
Dopo l'orario di chiusura:
31.79
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Storia dei dividendi
Precedente Chiudi:
$31.28
Aprire:
$31.05
Volume 24 ore:
5.75M
Relative Volume:
1.35
Capitalizzazione di mercato:
$13.78B
Reddito:
$2.27B
Utile/perdita netta:
$1.15B
Rapporto P/E:
12.47
EPS:
2.55
Flusso di cassa netto:
$2.80B
1 W Prestazione:
+0.44%
1M Prestazione:
-6.11%
6M Prestazione:
+14.56%
1 anno Prestazione:
+10.38%
Intervallo 1D:
$30.99
$31.85
Intervallo di 1 settimana:
$30.64
$31.85
Portata 52W:
$24.05
$34.20
Royalty Pharma Plc Stock (RPRX) Company Profile
Nome
Royalty Pharma Plc
Settore
Industria
Telefono
(212) 883-0200
Indirizzo
110 EAST 59TH STREET, NEW YORK, NY
Confronta RPRX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
RPRX
Royalty Pharma Plc
|
31.79 | 13.78B | 2.27B | 1.15B | 2.80B | 2.55 |
|
VRTX
Vertex Pharmaceuticals Inc
|
484.01 | 124.29B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
610.64 | 66.76B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
590.06 | 35.99B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
262.16 | 33.93B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
264.32 | 28.47B | 3.81B | -644.79M | -669.77M | -6.24 |
Royalty Pharma Plc Stock (RPRX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-06-03 | Downgrade | UBS | Buy → Neutral |
| 2022-06-14 | Ripresa | UBS | Buy |
| 2022-05-13 | Iniziato | Scotiabank | Sector Outperform |
| 2022-04-27 | Iniziato | Goldman | Buy |
| 2022-04-14 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2022-04-06 | Ripresa | Morgan Stanley | Overweight |
| 2021-10-29 | Aggiornamento | Citigroup | Neutral → Buy |
| 2021-07-30 | Iniziato | Tigress Financial | Buy |
| 2020-11-09 | Aggiornamento | UBS | Neutral → Buy |
| 2020-07-14 | Iniziato | Evercore ISI | In-line |
| 2020-07-13 | Iniziato | BofA Securities | Buy |
| 2020-07-13 | Iniziato | Citigroup | Neutral |
| 2020-07-13 | Iniziato | Cowen | Outperform |
| 2020-07-13 | Iniziato | Goldman | Neutral |
| 2020-07-13 | Iniziato | JP Morgan | Neutral |
| 2020-07-13 | Iniziato | Morgan Stanley | Equal-Weight |
| 2020-07-13 | Iniziato | SunTrust | Buy |
| 2020-07-13 | Iniziato | UBS | Neutral |
Mostra tutto
Royalty Pharma Plc Borsa (RPRX) Ultime notizie
Trexquant Investment LP Raises Position in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Vanguard Group Inc. Has $952.90 Million Stock Position in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
(RPRX) Investment Analysis and Advice - news.stocktradersdaily.com
Is Royalty Pharma plc (RPRX) The Most Profitable Biotech Stock To Buy Right Now? - Insider Monkey
Korea Investment CORP Grows Stock Position in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Norges Bank Takes Position in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Royalty Pharma plc (NASDAQ:RPRX) Receives Consensus Rating of "Buy" from Analysts - MarketBeat
Is Royalty Pharma Plc (RPRX) the Most Undervalued Healthcare Stock to Buy According to Analysts? - Yahoo Finance
Elo Mutual Pension Insurance Co Grows Holdings in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Sava Infond d.o.o. Purchases Shares of 21,000 Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Royalty Pharma Sees Unusually Large Options Volume (NASDAQ:RPRX) - MarketBeat
8 Most Undervalued Healthcare Stocks to Buy According to Analysts - Insider Monkey
Brandywine Global Investment Management LLC Raises Stock Holdings in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Homestead Advisers Corp Grows Stake in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Corient Private Wealth LLC Purchases 21,383 Shares of Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
7 Most Profitable Biotech Stocks To Buy Right Now - Insider Monkey
Royalty Pharma (NASDAQ:RPRX) Sees Strong Trading VolumeHere's Why - MarketBeat
KLP Kapitalforvaltning AS Invests $3.15 Million in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Mitsubishi UFJ Trust & Banking Corp Has $47.68 Million Holdings in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Teacher Retirement System of Texas Raises Holdings in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Virtu Financial LLC Invests $467,000 in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
4 Healthcare Stocks With Massive Gains—and More to Come - Benzinga
Royalty Pharma pullback a buying opportunity, says Citi - TipRanks
UBS maintains neutral Royalty Pharma stock with $33 target By Investing.com - Investing.com UK
UBS Reiterates Neutral Rating on Royalty Pharma (RPRX) - StreetInsider.com
Citi maintains Buy on Royalty Pharma stock with $40 target By Investing.com - Investing.com UK
Royalty Pharma Announces Upcoming Investor Day - The Manila Times
Citi Reiterates Buy Rating on Royalty Pharma (RPRX) - StreetInsider
Royalty Pharma's Investor Day: Strategic Roadmap for Biopharma Innovation Funding - Stock Titan
Sciencast Management LP Invests $998,000 in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Royalty Pharma plc (NASDAQ:RPRX) Stake Boosted by Royal London Asset Management Ltd. - MarketBeat
Thrivent Financial for Lutherans Increases Stock Holdings in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Proficio Capital Partners LLC Invests $786,000 in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Fox Run Management L.L.C. Purchases 16,084 Shares of Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Is Royalty Pharma plc (RPRX) The Best Defensive Stock Amid Market Volatility? - Yahoo Finance
15 Best Defensive Stocks Amid Market Volatility - Insider Monkey
Koss Olinger Consulting LLC Makes New $269,000 Investment in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Royalty Pharma plc (NASDAQ:RPRX) Shares Sold by HighTower Advisors LLC - MarketBeat
Royalty Pharma Plc Azioni (RPRX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
7.58%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):